Telestroke for acute ischaemic stroke: A systematic review of economic evaluations and a de novo cost-utility analysis for a middle income country.
Journal of Telemedicine and Telecare · 2021-07-22 · Systematic review
Abstract
INTRODUCTION: Telemedicine can alleviate the problems faced in rural settings in providing access to specialist stroke care. The evidence of the cost-effectiveness of this model of care outside high-income countries is limited. This study aimed to conduct: (a) a systematic review of economic evaluations of telestroke and (b) a cost-utility analysis of telestroke, using China as a case study. METHODS: We systematically searched Embase, Medline Complete and Cochrane databases. Inclusion criteria: full economic evaluations of telemedicine/telestroke networks examining the use of thrombolysis in patients with acute ischaemic stroke, published in English. A cost-utility analysis was undertaken using a Markov model incorporating a decision tree to simulate the delivery of telestroke for acute ischaemic stroke in rural China, compared to no telestroke from a societal and healthcare perspective. One-way deterministic sensitivity analyses and probabilistic sensitivity analyses were performed to test the robustness of results. RESULTS: Of 559 publications found, eight met the eligibility criteria and were included in the systematic review (two cost-effectiveness analyses and six cost-utility analyses, all performed in high-income countries). Telestroke was a cost-saving/cost-effective intervention in five out of the eight studies. In our modelled analysis for rural China, telestroke was the dominant strategy, with estimated cost savings of Chinese yuan 4,328 (US$627) and additional 0.0925 quality-adjusted life years per patient. Sensitivity analyses confirmed the base case results. DISCUSSION: Consistent with published economic evaluations of telestroke in other jurisdictions, telestroke represents a cost-effective solution to enhance stroke care in rural China.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Antithrombotics & thrombolytics · Cost & cost-effectiveness · Low- and middle-income settings · Quality of life & function · Rural & remote · Telemedicine · Thrombolytics
Related articles
- Is prehospital treatment of acute stroke too expensive? An economic evaluation based on the first trial. (Cerebrovasc Dis, 2014)
- Effectiveness of mobile stroke units in reducing time to thrombolysis in acute ischemic stroke: a scoping review. (Int J Emerg Med, 2025)
- Clinical outcomes after intravenous thrombolysis for acute ischemic stroke in low- and middle-income countries: a pooled analysis of 67,917 patients and systematic review. (Neurol Res, 2026)
- Cost-utility tele-stroke in adults with acute ischemic stroke. A systematic review. (Public Health Pract (Oxf), 2025)
- Is telestroke more effective than conventional treatment for acute ischemic stroke? A systematic review and meta-analysis of patient outcomes and thrombolysis rates. (Int J Stroke, 2024)
- Safety and efficacy of low-cost alternative urokinase in acute ischemic stroke: A systematic review and meta-analysis. (J Clin Neurosci, 2022)